Feline coronavirus replication is affected by both cyclophilin A and cyclophilin B

Journal of General Virology

Volumn 98, Issue 2, 2017, Pages 190-200

  Tanaka, Yoshikazu ^a   Sato, Yuka ^b   Sasaki, Takashi ^c  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^b THE UNIVERSITY OF TOKYO   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

Cyclophilin; Feline coronavirus; Feline infectious peritonitis; Peptidyl prolyl cis trans isomerase

Indexed keywords

CYCLOPHILIN A; CYCLOPHILIN B; PEPTIDYLPROLYL ISOMERASE; SHORT HAIRPIN RNA; VIRAL PROTEIN; CYCLOPHILIN; CYCLOSPORIN;

ARTICLE; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FELINE CORONAVIRUS; GENETIC TRANSFECTION; MOLECULAR WEIGHT; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE EXPRESSION; VECTOR CONTROL; VIRUS REPLICATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CAT; CELL LINE; DRUG EFFECTS; ENZYMOLOGY; FELINE INFECTIOUS PERITONITIS; GENE SILENCING; GENETICS; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANIMALS; CATALYTIC DOMAIN; CATS; CELL LINE; CORONAVIRUS, FELINE; CYCLOPHILIN A; CYCLOPHILINS; CYCLOSPORINE; FELINE INFECTIOUS PERITONITIS; GENE KNOCKDOWN TECHNIQUES; VIRUS REPLICATION;

EID: 85015628901     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000663     Document Type: Article

References (27)

1. Addie DD, Schaap IA, Nicolson L, Jarrett O. Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol 2003;84:2735-2744.
2. Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol 2009;7:439-450.
3. Pedersen NC. A review of feline infectious peritonitis virus infection: 1963-2008. J Feline Med Surg 2009;11:225-258.
4. Montali RJ, Strandberg JD. Extraperitoneal lesions in feline infectious peritonitis. Vet Pathol 1972;9:109-121.
5. de Haan CA, Rottier PJ. Hosting the severe acute respiratory syndrome coronavirus: specific cell factors required for infection. Cell Microbiol 2006;8:1211-1218.
6. Vogels MW, van Balkom BW, Kaloyanova DV, Batenburg JJ, Heck AJ et al. Identification of host factors involved in coronavirus replication by quantitative proteomics analysis. Proteomics 2011;11: 64-80.
7. Siekierka JJ, Hung SH, Poe M, Lin CS, Sigal NH. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 1989; 341:755-757.
8. Takahashi N, Hayano T, Suzuki M. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 1989;337:473-475.
9. de Wilde AH, Zevenhoven-Dobbe JC, van der Meer Y, Thiel V, Narayanan K et al. Cyclosporin A inhibits the replication of diverse coronaviruses. J Gen Virol 2011;92:2542-2548.
10. Pfefferle S, Schöpf J, Kögl M, Friedel CC, Müller MA et al. The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog 2011;7:e1002331.
11. Tanaka Y, Sato Y, Osawa S, Inoue M, Tanaka S et al. Suppression of feline coronavirus replication in vitro by cyclosporin A. Vet Res 2012;43:41.
12. von Brunn A, Ciesek S, von Brunn B, Carbajo-Lozoya J. Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for human coronavirus 229E replication. Curr Opin Virol 2015; 14:56-61.
13. Carbajo-Lozoya J, Müller MA, Kallies S, Thiel V, Drosten C et al. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. Virus Res 2012;165: 112-117.
14. Carbajo-Lozoya J, Ma-Lauer Y, Maleševic´ M, Theuerkorn M, Kahlert V et al. Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir. Virus Res 2014;184:44-53.
15. Spik G, Haendler B, Delmas O, Mariller C, Chamoux M et al. A novel secreted cyclophilin-like protein (SCYLP). J Biol Chem 1991; 266:10735-10738.
16. Zydowsky LD, Etzkorn FA, Chang HY, Ferguson SB, Stolz LA et al. Active site mutants of human cyclophilin A separate peptidylprolyl isomerase activity from cyclosporin A binding and calcineurin inhibition. Protein Sci 1992;1:1092-1099.
17. Carpentier M, Allain F, Haendler B, Denys A, Mariller C et al. Two distinct regions of cyclophilin B are involved in the recognition of a functional receptor and of glycosaminoglycans on T lymphocytes. J Biol Chem 1999;274:10990-10998.
18. Tanaka Y, Amano A, Morisaki M, Sato Y, Sasaki T. Cellular peptidyl-prolyl cis/trans isomerase Pin1 facilitates replication of feline coronavirus. Antiviral Res 2016;126:1-7.
19. Hopkins S, Gallay PA. The role of immunophilins in viral infection. Biochim Biophys Acta 2015;1850:2103-2110.
20. Fischer G, Wittmann-Liebold B, Lang K, Kiefhaber T, Schmid FX. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 1989;337:476-478.
21. Spencer KA, Hiscox JA. Characterisation of the RNA binding properties of the coronavirus infectious bronchitis virus nucleocapsid protein amino-terminal region. FEBS Lett 2006;580:5993-5998.
22. Zúñiga S, Sola I, Moreno JL, Sabella P, Plana-Duran J et al. Coronavirus nucleocapsid protein is an RNA chaperone. Virology 2007; 357:215-227.
23. Zúñiga S, Cruz JL, Sola I, Mateos-Gómez PA, Palacio L et al. Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription. J Virol 2010;84:2169-2175.
24. Wu CH, Chen PJ, Yeh SH. Nucleocapsid phosphorylation and RNA helicase DDX1 recruitment enables coronavirus transition from discontinuous to continuous transcription. Cell Host Microbe 2014; 16:462-472.
25. Luo C, Luo H, Zheng S, Gui C, Yue L et al. Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. Biochem Biophys Res Commun 2004;321:557-565.
26. Carpentier M, Allain F, Haendler B, Slomianny MC, Spik G. Delineation of the calcineurin-interacting region of cyclophilin B. Protein Sci 2000;9:2386-2393.
27. Yang F, Robotham JM, Nelson HB, Irsigler A, Kenworthy R et al. Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro. J Virol 2008;82:5269-5278